DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 80
SponsorQueen Mary Hospital, Hong Kong
About this trial
To study the correlation between novel DIC markers and thrombin generation parameters with thrombotic and hemorrhagic complications of patients on ECMO support.
Eligibility criteria
Qualifiers
Age ≧ 18; AND
Admitted to the mixed medical-surgical intensive care units of Queen Mary Hospital or Tuen Mun Hospital in Hong Kong; AND
Require either veno-arterial (VA) or veno-venous (VV) extracorporeal membrane oxygenation (ECMO) support.
Disqualifiers
Patients who are on central VA-ECMO support; OR
Patients with missing clinical data; OR
Patients with pre-existing thromboembolism requiring long term anticoagulation prior to ECMO cannulation; OR
Post-operative admissions
Trial design
Treatments tested in this trial
- DIC markers and Thrombin Generation Parameters
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
1Queen Mary Hospital Hong Kong Hong Kong
Sponsors and collaborators
Queen Mary Hospital, Hong Kong
Lead sponsor
Source ClinicalTrials.gov